December 22 (SeeNews) - Croatian pharmaceuticals maker Jadran Galenski Laboratorij (JGL) said it has placed 200 million kuna ($28.5 million/26.1 million euro) in five-year corporate bonds.
The bonds, carrying a fixed interest of 5.8125% and issued at price equal to 99.839% of par, will mature on December 21, 2020, the company said in statement filed with the Zagreb bourse on Monday.
The company will use a portion of the collected funds to refinance and repay existing debt.
Founded in 1991, JGL is the second largest pharmaceuticals maker in Croatia, specialising in the production of sterile nose, eye and ear drop solutions.
(1 euro=7.65334 Croatian kuna)